Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Satoshi Ueshima"'
Autor:
Tetsuichiro Isono, Daiki Hira, Aya Morikochi, Tadateru Fukami, Satoshi Ueshima, Kazuhiko Nozaki, Tomohiro Terada, Shin‐ya Morita
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
Abstract High‐dose methotrexate (HD‐MTX)‐based chemotherapy is the first‐line treatment for primary central nervous system lymphoma (PCNSL), but is associated with severe adverse effects, including myelosuppression and renal impairment. MTX i
Externí odkaz:
https://doaj.org/article/824d53c5e02641dda3a283c8be708d12
Autor:
Qi Wu, Hideki Hayashi, Daiki Hira, Keiko Sonoda, Satoshi Ueshima, Seiko Ohno, Takeru Makiyama, Tomohiro Terada, Toshiya Katsura, Katsuyuki Miura, Minoru Horie
Publikováno v:
Journal of Arrhythmia, Vol 35, Iss 5, Pp 752-759 (2019)
Abstract Background Patients with Brugada syndrome (BrS) are known to have arrhythmic events after alcohol drinking and are recommended to avoid its excessive intake. Mechanisms underlying the alcohol‐induced cardiac events are however unknown. Thi
Externí odkaz:
https://doaj.org/article/e95dfb37faba4005bbede25cf9881366
Publikováno v:
Biopharmaceutics & Drug Disposition.
Publikováno v:
Biochemical and Biophysical Research Communications. 554:151-157
It has been suggested that the intelligence quotient of children born to pregnant women taking 1000 mg or more of valproic acid per day is lower than that of children born to pregnant women taking other antiepileptic drugs. However, the mechanism whe
1. We investigated the changes in the expression of drug-metabolising enzymes and drug transporters in the liver, small intestine and kidney of mice with collagen antibody-induced arthritis (CAIA) to determine whether changes in these expressions aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3253807ce09ca145f5b4c5cadc71c733
Autor:
Tadateru Fukami, Daiki Hira, Aya Morikochi, Tomohiro Terada, Satoshi Ueshima, Tetsuichiro Isono, Shin-ya Morita, Kazuhiko Nozaki
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 6, Pp n/a-n/a (2021)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
High‐dose methotrexate (HD‐MTX)‐based chemotherapy is the first‐line treatment for primary central nervous system lymphoma (PCNSL), but is associated with severe adverse effects, including myelosuppression and renal impairment. MTX is primari
Autor:
Seiko Ohno, Hideki Hayashi, Qi Wu, Tomohiro Terada, Satoshi Ueshima, Toshiya Katsura, Daiki Hira, Takeru Makiyama, Minoru Horie, Keiko Sonoda, Katsuyuki Miura
Publikováno v:
Journal of Arrhythmia, Vol 35, Iss 5, Pp 752-759 (2019)
Journal of Arrhythmia
Journal of Arrhythmia
Background Patients with Brugada syndrome (BrS) are known to have arrhythmic events after alcohol drinking and are recommended to avoid its excessive intake. Mechanisms underlying the alcohol‐induced cardiac events are however unknown. This study a
Autor:
Kana Suenaga, Yasutaka Nakano, Satoshi Ueshima, Tomoyuki Okuda, Daiki Hira, Masafumi Yamaguchi, Eri Ishido, Hirokazu Okamoto, Hiroyoshi Koide, Shin-ya Morita, Mikio Kakumoto, Tomohiro Terada, Tomonobu Okano
Publikováno v:
Biologicalpharmaceutical bulletin. 44(6)
It is well known that correct use of inhalers plays a critical role in optimal inhalation therapy, but the impact of incorrect inhaler use on pulmonary drug delivery has not been quantitatively evaluated. The aim of this study was to investigate the
Autor:
Ikuo Kawamoto, Satoshi Ueshima, Daiki Hira, Tomoya Kitagawa, Taku Imamura, Tomohiro Terada, Mikio Kakumoto, Masahito Ohji, Mitsuru Murase, Masashi Kakinoki
Publikováno v:
Translational Vision Science & Technology
Purpose:This study evaluated the pharmacokinetics of intravitreal vancomycin and ceftazidime in the aqueous humor of macaque eyes filled with silicone oil in the vitreous cavity.
Methods:Intravitreal vancomycin (1 mg/0.1 mL) and ceftazidime (2 m
Methods:Intravitreal vancomycin (1 mg/0.1 mL) and ceftazidime (2 m
Autor:
Hideki Itoh, Tomohiro Terada, Tetsuichiro Isono, Satoshi Ueshima, Daiki Hira, Rika Fukui, Yuki Kunitsu, Yohei Tabuchi, Yoshihiro Ikuno, Toshihiro Tanaka
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
In clinical practice, edoxaban is sometimes prescribed for off-label use based on the hypothesis that it is as safe and effective as warfarin. However, there is limited safety information on off-label use due to lack of clinical trial. We aimed to an